QUANTUMONLINE.COM SECURITY DESCRIPTION:  Merrill Lynch & Co. Inc. Accelerated Return Notes linked to the AMEX Biotechnology Index, due 10/05/2004, issued at $10 per unit. The notes will receive no payments before maturity, are not redeemable prior to maturity, and make no guarantee of the return of principal at maturity. At maturity the holder will receive a payment based on the percentage change in the AMEX Biotechnology Index (AMEX symbol BTK, starting value 458.63 as of 7/30/2003). If the Index has increased, the maturity payment will be based on triple the percentage increase in the AMEX Biotechnology Index, not to exceed $11.80 per note. If the index has decreased, the holder will receive a payment based on the full percentage of decrease. As a result, the maturity payment may be less, and possibly significantly less, than the $10 offering price. The notes are senior unsecured debt securities issued by Merrill Lynch & Co. Inc. and rank equally with all of their other unsecured and unsubordinated debt. See the IPO prospectus for further information on the maturity payment and the Accelerated Return Notes by using the link provided below. See the IPO prospectus for further information on the Accelerated Return Notes and their maturity payment by clicking on the ‘Link to IPO Prospectus’ provided below.

Company's Online Information Links

HOME PAGE:     http://www.ml.com/ (This parent company URL is for reference only and does not have specific information on the security.)

Company's Online SEC EDGAR Filings

Company's SEC EDGAR Filings

Go to SEC Filings

Company's Email Address Links

Email Address	investor_relations@ml.com
Email Contact Form on Website	Go to Email Form

Address and Phone Numbers

Address:   4 World Financial Center, North Tower, New York, NY 10080
Main Phone Number	212-449-1000
Fax Number	212-236-4384
Investor Relations	866-607-1234
Toll Free Phone Number	800-637-7455

CEO - David H. Komansky

CFO - Thomas H. Patrick